HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-MAR-13 4JI9 TITLE JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: JH1 DOMAIN, UNP RESIDUES 833-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, PHOSPHO-TRANSFER CATALYST, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.EIGENBROT,M.ULTSCH REVDAT 2 21-AUG-13 4JI9 1 JRNL REVDAT 1 07-AUG-13 4JI9 0 JRNL AUTH M.SIU,R.PASTOR,W.LIU,K.BARRETT,M.BERRY,W.S.BLAIR,C.CHANG, JRNL AUTH 2 J.Z.CHEN,C.EIGENBROT,N.GHILARDI,P.GIBBONS,H.HE,C.A.HURLEY, JRNL AUTH 3 J.R.KENNY,S.CYRUS KHOJASTEH,H.LE,L.LEE,J.P.LYSSIKATOS, JRNL AUTH 4 S.MAGNUSON,R.PULK,V.TSUI,M.ULTSCH,Y.XIAO,B.Y.ZHU,D.SAMPATH JRNL TITL 2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINES AS JAK2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 5014 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23870430 JRNL DOI 10.1016/J.BMCL.2013.06.008 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 33915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 846 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.53 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4601 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.3510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4779 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.81000 REMARK 3 B22 (A**2) : 0.81000 REMARK 3 B33 (A**2) : -1.63000 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : -0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.300 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.230 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.174 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.357 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4960 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6693 ; 1.173 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 572 ; 5.604 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 248 ;37.950 ;24.274 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 915 ;15.073 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 35 ;17.165 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 697 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3747 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4JI9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-13. REMARK 100 THE RCSB ID CODE IS RCSB078079. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33915 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: PDB ENTRY 2B7A REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM ACETATE, PEG8000, PH 6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.23350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.61675 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.85025 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 833 REMARK 465 GLY A 834 REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ARG A 923 REMARK 465 SER B 833 REMARK 465 GLY B 834 REMARK 465 ALA B 835 REMARK 465 PHE B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ALA B 920 REMARK 465 GLY B 921 REMARK 465 ARG B 922 REMARK 465 ARG B 923 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 859 -115.19 59.21 REMARK 500 GLN A 872 19.93 51.12 REMARK 500 ARG A 975 -32.58 76.43 REMARK 500 TRP A1106 38.09 -89.95 REMARK 500 ASP B 840 98.83 17.29 REMARK 500 ARG B 975 -23.37 75.70 REMARK 500 GLU B1012 107.35 78.19 REMARK 500 TRP B1106 39.70 -95.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1M3 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1M3 B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4JIA RELATED DB: PDB DBREF 4JI9 A 833 1132 UNP O60674 JAK2_HUMAN 833 1132 DBREF 4JI9 B 833 1132 UNP O60674 JAK2_HUMAN 833 1132 SEQRES 1 A 300 SER GLY ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU SEQRES 2 A 300 GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY SEQRES 3 A 300 ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU SEQRES 4 A 300 GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU SEQRES 5 A 300 GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG SEQRES 6 A 300 GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE SEQRES 7 A 300 VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG SEQRES 8 A 300 ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER SEQRES 9 A 300 LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP SEQRES 10 A 300 HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS SEQRES 11 A 300 GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG SEQRES 12 A 300 ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN SEQRES 13 A 300 ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU SEQRES 14 A 300 PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY SEQRES 15 A 300 GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR SEQRES 16 A 300 GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE SEQRES 17 A 300 GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SEQRES 18 A 300 SER LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY SEQRES 19 A 300 ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE SEQRES 20 A 300 GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP SEQRES 21 A 300 GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS SEQRES 22 A 300 TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP SEQRES 23 A 300 LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA SEQRES 24 A 300 GLY SEQRES 1 B 300 SER GLY ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU SEQRES 2 B 300 GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY SEQRES 3 B 300 ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU SEQRES 4 B 300 GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU SEQRES 5 B 300 GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG SEQRES 6 B 300 GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE SEQRES 7 B 300 VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG SEQRES 8 B 300 ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER SEQRES 9 B 300 LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP SEQRES 10 B 300 HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS SEQRES 11 B 300 GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG SEQRES 12 B 300 ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN SEQRES 13 B 300 ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU SEQRES 14 B 300 PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY SEQRES 15 B 300 GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR SEQRES 16 B 300 GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE SEQRES 17 B 300 GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SEQRES 18 B 300 SER LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY SEQRES 19 B 300 ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE SEQRES 20 B 300 GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP SEQRES 21 B 300 GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS SEQRES 22 B 300 TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP SEQRES 23 B 300 LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA SEQRES 24 B 300 GLY MODRES 4JI9 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 4JI9 PTR A 1008 TYR O-PHOSPHOTYROSINE MODRES 4JI9 PTR B 1007 TYR O-PHOSPHOTYROSINE MODRES 4JI9 PTR B 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 1M3 A1201 36 HET 1M3 B1201 36 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1M3 N-TERT-BUTYL-3-[(5-METHYL-2-{[4-(4-METHYLPIPERAZIN-1- HETNAM 2 1M3 YL)PHENYL]AMINO}PYRIMIDIN-4-YL) HETNAM 3 1M3 AMINO]BENZENESULFONAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 1M3 2(C26 H35 N7 O2 S) FORMUL 5 HOH *110(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 GLU A 889 SER A 904 1 16 HELIX 3 3 SER A 936 HIS A 944 1 9 HELIX 4 4 ASP A 949 THR A 969 1 21 HELIX 5 5 ALA A 978 ARG A 980 5 3 HELIX 6 6 PRO A 1017 TYR A 1021 5 5 HELIX 7 7 ALA A 1022 GLU A 1028 1 7 HELIX 8 8 VAL A 1033 THR A 1049 1 17 HELIX 9 9 GLU A 1052 LYS A 1055 5 4 HELIX 10 10 SER A 1056 GLY A 1066 1 11 HELIX 11 11 GLN A 1070 ASN A 1084 1 15 HELIX 12 12 PRO A 1095 TRP A 1106 1 12 HELIX 13 13 ASN A 1109 ARG A 1113 5 5 HELIX 14 14 SER A 1115 GLY A 1132 1 18 HELIX 15 15 GLU B 845 ARG B 847 5 3 HELIX 16 16 THR B 888 LEU B 905 1 18 HELIX 17 17 SER B 936 LYS B 945 1 10 HELIX 18 18 ASP B 949 LYS B 970 1 22 HELIX 19 19 PRO B 1017 TYR B 1021 5 5 HELIX 20 20 ALA B 1022 SER B 1029 1 8 HELIX 21 21 SER B 1032 THR B 1049 1 18 HELIX 22 22 GLU B 1052 LYS B 1055 5 4 HELIX 23 23 SER B 1056 GLY B 1066 1 11 HELIX 24 24 GLN B 1070 ASN B 1084 1 15 HELIX 25 25 PRO B 1095 TRP B 1106 1 12 HELIX 26 26 ASN B 1109 ARG B 1113 5 5 HELIX 27 27 SER B 1115 GLY B 1132 1 18 SHEET 1 A 5 LEU A 849 GLY A 858 0 SHEET 2 A 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1007 LYS A1009 0 SHEET 2 D 2 LYS A1030 SER A1032 -1 O PHE A1031 N PTR A1008 SHEET 1 E 5 LEU B 849 LYS B 857 0 SHEET 2 E 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 E 5 VAL B 878 LEU B 884 -1 O VAL B 881 N GLU B 864 SHEET 4 E 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 E 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928 SHEET 1 F 2 TYR B 972 ILE B 973 0 SHEET 2 F 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 G 2 ILE B 982 ASN B 986 0 SHEET 2 G 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 H 2 PTR B1008 LYS B1009 0 SHEET 2 H 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.33 SITE 1 AC1 14 LEU A 855 GLY A 856 LYS A 857 GLY A 858 SITE 2 AC1 14 ALA A 880 GLU A 930 TYR A 931 LEU A 932 SITE 3 AC1 14 GLY A 935 ASN A 981 LEU A 983 GLY A 993 SITE 4 AC1 14 ASP A 994 HOH A1301 SITE 1 AC2 13 LEU B 855 GLY B 858 ALA B 880 VAL B 911 SITE 2 AC2 13 GLU B 930 TYR B 931 LEU B 932 GLY B 935 SITE 3 AC2 13 ASN B 981 LEU B 983 GLY B 993 ASP B 994 SITE 4 AC2 13 HOH B1318 CRYST1 111.992 111.992 70.467 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008929 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008929 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014191 0.00000